• Explore /
  • Poster
  • / Pembrolizumab monotherapy for patients with advanced MSI-H colorectal cancer: Longer-term follow-up of the phase II, KEYNOTE-164 study.

Pembrolizumab monotherapy for patients with advanced MSI-H colorectal cancer: Longer-term follow-up of the phase II, KEYNOTE-164 study.

Abstract Poster

Authors

null

Luis A. Diaz Jr.

Memorial Sloan Kettering Cancer Center, New York, NY

Luis A. Diaz Jr., Dung T. Le , Tae Won Kim , Eric Van Cutsem , Ravit Geva , Dirk Jaeger , Hiroki Hara , Matthew E. Burge , Bert H. O'Neil , Petr Kavan , Takayuki Yoshino , Rosine Guimbaud , Hiroya Taniguchi , Elena Elez , Salah-Eddin Al-Batran , Patrick M Boland , Yi Cui , Carlos Alberto Mayo , Patricia Marinello , Thierry Andre

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT02460198

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4032)

DOI

10.1200/JCO.2020.38.15_suppl.4032

Abstract #

4032

Poster Bd #

24

Abstract Disclosures

Similar Posters

First Author: Dung T. Le

First Author: Dung T. Le

First Author: Dung T. Le

First Author: Desamparados Roda